China Universal Asset Management Company’s CG Oncology CGON Stock Holding History

China Universal Asset Management Company’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$997K	Sell	14,037 -947	-6%	-$61.9K	0.06%	206
2026 Q1	$1.01M	Buy	14,984 +1,839	+14%	+$104K	0.08%	188
2025 Q4	$546K	Sell	13,145 -220	-2%	-$9.1K	0.04%	250
2025 Q3	$538K	Sell	13,365 -1,945	-13%	-$56.5K	0.04%	240
2025 Q2	$398K	Buy	15,310 +40	+0.3%	+$964	0.04%	260
2025 Q1	$374K	Buy	15,270 +930	+6%	+$26.2K	0.03%	269
2024 Q4	$411K	Buy	+14,340	New	+$491K	0.04%	269

Other funds holding CGON

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

Eleva Capital Paris, France $343M AUM

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

China Universal Asset Management Company's CGON Position: Q2 2026 in Review

China Universal Asset Management Company reduced its CG Oncology (CGON) stake by 6.3% in Q2 2026, selling an estimated $61.9K and leaving 14,037 shares worth $997K. The position accounts for 0.06% of the portfolio, ranked #206.

China Universal Asset Management Company first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.01M in Q1 2026. 26 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

China Universal Asset Management Company held 14,037 shares of CG Oncology worth $997K as of Q2 2026.
China Universal Asset Management Company sold 947 CG Oncology shares in Q2 2026, an estimated $61.9K.
CG Oncology made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #206 holding.
China Universal Asset Management Company first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
China Universal Asset Management Company's CG Oncology position peaked at $1.01M in Q1 2026.
26 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.